| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82293-009-10 | 82293-009 | HUMAN PRESCRIPTION DRUG | Lenalidomide | Lenalidomide | CAPSULE | ORAL | 20260106 | N/A | ANDA | ANDA217281 | Novugen Pharma (USA) LLC | LENALIDOMIDE | 15 mg/1 | 21 CAPSULE in 1 BOTTLE (82293-009-10) |
| 82293-010-10 | 82293-010 | HUMAN PRESCRIPTION DRUG | Lenalidomide | Lenalidomide | CAPSULE | ORAL | 20260106 | N/A | ANDA | ANDA217281 | Novugen Pharma (USA) LLC | LENALIDOMIDE | 20 mg/1 | 21 CAPSULE in 1 BOTTLE (82293-010-10) |
| 82293-011-10 | 82293-011 | HUMAN PRESCRIPTION DRUG | Lenalidomide | Lenalidomide | CAPSULE | ORAL | 20260106 | N/A | ANDA | ANDA217281 | Novugen Pharma (USA) LLC | LENALIDOMIDE | 25 mg/1 | 21 CAPSULE in 1 BOTTLE (82293-011-10) |
| 82293-008-10 | 82293-008 | HUMAN PRESCRIPTION DRUG | Lenalidomide | Lenalidomide | CAPSULE | ORAL | 20260106 | N/A | ANDA | ANDA217281 | Novugen Pharma (USA) LLC | LENALIDOMIDE | 10 mg/1 | 28 CAPSULE in 1 BOTTLE (82293-008-10) |
| 82293-007-10 | 82293-007 | HUMAN PRESCRIPTION DRUG | Lenalidomide | Lenalidomide | CAPSULE | ORAL | 20260106 | N/A | ANDA | ANDA217281 | Novugen Pharma (USA) LLC | LENALIDOMIDE | 5 mg/1 | 28 CAPSULE in 1 BOTTLE (82293-007-10) |
| 82293-006-10 | 82293-006 | HUMAN PRESCRIPTION DRUG | Lenalidomide | Lenalidomide | CAPSULE | ORAL | 20260106 | N/A | ANDA | ANDA217281 | Novugen Pharma (USA) LLC | LENALIDOMIDE | 2.5 mg/1 | 28 CAPSULE in 1 BOTTLE (82293-006-10) |